NIPPON INDIA PHARMA FUND - GROWTH PLAN - GROWTH OPTION

Thematic • Very High Risk

NIPPON INDIA PHARMA FUND - GROWTH PLAN - GROWTH OPTION

Category: Thematic

CRISIL Rating: Very High Risk

Code: PHGP

NAV

₹506.02

6.92 (1.36%)
2026-02-19
Fund Rating

3 ⭐

Fund Information
Fund Size (AUM): 787.54 CR
Fund Strategy: Very High Risk
Expense Ratio: 1.8200%
Fund Manager:
Min Lump Sum: ₹5,000.00
Min SIP: ₹100.00
ISIN: INF204K01968
Benchmark:
22.80% 3Y annualised
NAV

₹506.02

2026-02-19
Fund Rating

3 ⭐

Fund Size

787.54 CR

Fund Strategy

Very High Risk

₹500 ₹100,000
Total Investment: ₹15,000
Total Value: ₹0
Login to Invest

Login to create portfolios and start investing

Sector Allocation
Top Holdings
Security Name Weight (%)
Sun Pharmaceuticals Industries Ltd 12.23%
Divi's Laboratories Ltd 8.50%
Lupin Ltd 6.07%
Cipla Ltd 5.62%
Apollo Hospitals Enterprise Ltd 5.48%
Dr Reddy's Laboratories Ltd 5.18%
Medplus Health Services Ltd 3.83%
GlaxoSmithKline Pharmaceuticals Ltd 3.63%
Narayana Hrudayalaya Ltd 3.55%
Vijaya Diagnostic Centre Ltd 3.32%

Fund Rating

3 out of 5

Funds in Same Category

No other funds found in this category.